| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Cardiotoxicity of antiemetic drugs in oncology: An overview of the current state of the art
|
Barni, Sandro
|
|
2016
|
102 |
C |
p. 125-134
10 p.
|
artikel
|
| 2 |
Cisplatin versus carboplatin: comparative review of therapeutic management in solid malignancies
|
Ho, Gwo Yaw
|
|
2016
|
102 |
C |
p. 37-46
10 p.
|
artikel
|
| 3 |
Clear cell carcinoma, not otherwise specified/hyalinising clear cell carcinoma of the salivary gland: The current nomenclature, clinical/pathological characteristics and management
|
Daniele, Luca
|
|
2016
|
102 |
C |
p. 55-64
10 p.
|
artikel
|
| 4 |
Continuous versus intermittent docetaxel for metastatic castration resistant prostate cancer
|
Gyawali, Bishal
|
|
2016
|
102 |
C |
p. 118-124
7 p.
|
artikel
|
| 5 |
Editorial Board
|
|
|
2016
|
102 |
C |
p. IFC-
1 p.
|
artikel
|
| 6 |
Efficacy and mucosal toxicity of concomitant chemo-radiotherapy in patients with locally-advanced squamous cell carcinoma of the head-and-neck in the light of a novel mathematical model
|
Strigari, Lidia
|
|
2016
|
102 |
C |
p. 101-110
10 p.
|
artikel
|
| 7 |
Epirubicin-based compared with docetaxel-based chemotherapy for advanced gastric carcinoma: A systematic review and meta-analysis
|
Petrioli, Roberto
|
|
2016
|
102 |
C |
p. 82-88
7 p.
|
artikel
|
| 8 |
Erratum to “Role of radiation therapy in melanomas: Systematic review and best practice in 2015” [Crit. Rev. Oncol./Hematol. 99 (2016) 362–375]
|
Fort, Magali
|
|
2016
|
102 |
C |
p. 144-
1 p.
|
artikel
|
| 9 |
Erratum to “Role of radiation therapy in non-melanoma cancers, lymphomas and sarcomas of the skin: Systematic review and best practice in 2016” [Crit. Rev. Oncol./Hematol. 99 (2016) 200–213]
|
Fort, Magali
|
|
2016
|
102 |
C |
p. 145-
1 p.
|
artikel
|
| 10 |
High-risk prostate cancer: the role of surgical management
|
Morlacco, Alessandro
|
|
2016
|
102 |
C |
p. 135-143
9 p.
|
artikel
|
| 11 |
Hyponatremia in cancer patients: Time for a new approach
|
Berardi, Rossana
|
|
2016
|
102 |
C |
p. 15-25
11 p.
|
artikel
|
| 12 |
Mucinous ovarian cancer: A therapeutic review
|
Xu, Wen
|
|
2016
|
102 |
C |
p. 26-36
11 p.
|
artikel
|
| 13 |
Optimizing clinical benefit with targeted treatment in mRCC: “Tumor growth rate” as an alternative clinical endpoint
|
Milella, Michele
|
|
2016
|
102 |
C |
p. 73-81
9 p.
|
artikel
|
| 14 |
Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Xerostomia and trismus (Part 2). Literature review and consensus statement
|
Buglione, Michela
|
|
2016
|
102 |
C |
p. 47-54
8 p.
|
artikel
|
| 15 |
Risk of cardiovascular adverse events in patients with solid tumors treated with ramucirumab: A meta analysis and summary of other VEGF targeted agents
|
Abdel-Rahman, Omar
|
|
2016
|
102 |
C |
p. 89-100
12 p.
|
artikel
|
| 16 |
Should we include SPECT lung perfusion in radiotherapy treatment plans of thoracic targets? Evidences from the literature
|
De Bari, Berardino
|
|
2016
|
102 |
C |
p. 111-117
7 p.
|
artikel
|
| 17 |
Ten years of HPV vaccines: State of art and controversies
|
Angioli, Roberto
|
|
2016
|
102 |
C |
p. 65-72
8 p.
|
artikel
|
| 18 |
Timing of breast cancer surgery, menstrual phase, and prognosis: Systematic review and meta-analysis
|
Klonoff-Cohen, Hillary
|
|
2016
|
102 |
C |
p. 1-14
14 p.
|
artikel
|
Tijdschrift beschrijving